In the broader context of pharmacogenomics, while the apparent loss of ABCC2 function resulting in increased exposure to vincristine is indicative of a central role in the drug’s elimination, neither CNS toxicity or marked peripheral neuropathy were noted, indicative of a minimal role for ABCC2 in protection against vincristine induced neurotoxicity. This evidence concerns the gene ABCC2 and peripheral neuropathy.